179 related articles for article (PubMed ID: 29848510)
1. Prorenin independently causes hypertension and renal and cardiac fibrosis in cyp1a1-prorenin transgenic rats.
Zhou G; Wu J; Gu C; Wang B; Abel ED; Cheung AK; Huang Y
Clin Sci (Lond); 2018 Jun; 132(12):1345-1363. PubMed ID: 29848510
[TBL] [Abstract][Full Text] [Related]
2. Lack of cardiac fibrosis in a new model of high prorenin hyperaldosteronism.
Peters J; Schlüter T; Riegel T; Peters BS; Beineke A; Maschke U; Hosten N; Mullins JJ; Rettig R
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1845-52. PubMed ID: 19749160
[TBL] [Abstract][Full Text] [Related]
3. Prorenin contributes to angiotensin peptide formation in transgenic rats with rat prorenin expression targeted to the liver.
Campbell DJ; Karam H; Ménard J; Bruneval P; Mullins JJ
Hypertension; 2009 Dec; 54(6):1248-53. PubMed ID: 19841286
[TBL] [Abstract][Full Text] [Related]
4. High salt intake damages the heart through activation of cardiac (pro) renin receptors even at an early stage of hypertension.
Hayakawa Y; Aoyama T; Yokoyama C; Okamoto C; Komaki H; Minatoguchi S; Iwasa M; Yamada Y; Kawamura I; Kawasaki M; Nishigaki K; Mikami A; Suzuki F; Minatoguchi S
PLoS One; 2015; 10(3):e0120453. PubMed ID: 25799069
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent titration of prorenin and blood pressure in Cyp1a1ren-2 transgenic rats: absence of prorenin-induced glomerulosclerosis.
Peters B; Grisk O; Becher B; Wanka H; Kuttler B; Lüdemann J; Lorenz G; Rettig R; Mullins JJ; Peters J
J Hypertens; 2008 Jan; 26(1):102-9. PubMed ID: 18090546
[TBL] [Abstract][Full Text] [Related]
6. Increased dietary NaCl potentiates the effects of elevated prorenin levels on blood pressure and organ disease.
Campbell DJ; Karam H; Bruneval P; Mullins JJ; Ménard J
J Hypertens; 2010 Jul; 28(7):1429-37. PubMed ID: 20453664
[TBL] [Abstract][Full Text] [Related]
7. Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension.
Ichihara A; Kaneshiro Y; Takemitsu T; Sakoda M; Suzuki F; Nakagawa T; Nishiyama A; Inagami T; Hayashi M
Hypertension; 2006 May; 47(5):894-900. PubMed ID: 16585419
[TBL] [Abstract][Full Text] [Related]
8. Chronic increases in circulating prorenin are not associated with renal or cardiac pathologies.
Mercure C; Prescott G; Lacombe MJ; Silversides DW; Reudelhuber TL
Hypertension; 2009 Jun; 53(6):1062-9. PubMed ID: 19364992
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of renin and prorenin receptor in collecting duct of Cyp1a1-Ren2 rats may contribute to development and progression of malignant hypertension.
Prieto MC; Williams DE; Liu L; Kavanagh KL; Mullins JJ; Mitchell KD
Am J Physiol Renal Physiol; 2011 Feb; 300(2):F581-8. PubMed ID: 21068087
[TBL] [Abstract][Full Text] [Related]
10. Cardiac remodeling during and after renin-angiotensin system stimulation in Cyp1a1-Ren2 transgenic rats.
Heijnen BF; Pelkmans LP; Danser AH; Garrelds IM; Mullins JJ; De Mey JG; Struijker-Boudier HA; Janssen BJ
J Renin Angiotensin Aldosterone Syst; 2014 Mar; 15(1):69-81. PubMed ID: 23462119
[TBL] [Abstract][Full Text] [Related]
11. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
Mitchell KD; Bagatell SJ; Miller CS; Mouton CR; Seth DM; Mullins JJ
J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061
[TBL] [Abstract][Full Text] [Related]
12. Transgenic rats carrying the mouse renin gene--morphological characterization of a low-renin hypertension model.
Bachmann S; Peters J; Engler E; Ganten D; Mullins J
Kidney Int; 1992 Jan; 41(1):24-36. PubMed ID: 1593860
[TBL] [Abstract][Full Text] [Related]
13. Transient renin-angiotensin system stimulation in an early stage of life causes sustained hypertension in rats.
Heijnen BF; Peutz-Kootstra CJ; Mullins JJ; Janssen BJ; Struijker-Boudier HA
J Hypertens; 2011 Dec; 29(12):2369-80. PubMed ID: 22025236
[TBL] [Abstract][Full Text] [Related]
14. Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats.
Pilz B; Shagdarsuren E; Wellner M; Fiebeler A; Dechend R; Gratze P; Meiners S; Feldman DL; Webb RL; Garrelds IM; Jan Danser AH; Luft FC; Müller DN
Hypertension; 2005 Sep; 46(3):569-76. PubMed ID: 16103264
[TBL] [Abstract][Full Text] [Related]
15. Direct renin inhibition with aliskiren normalizes blood pressure in Cyp1a1-Ren2 transgenic rats with inducible angiotensin ii-dependent malignant hypertension.
Howard CG; Mullins JJ; Mitchell KD
Am J Med Sci; 2011 May; 341(5):383-7. PubMed ID: 21358304
[TBL] [Abstract][Full Text] [Related]
16. Impairment of the autoregulation of renal hemodynamics and of the pressure-natriuresis relationship precedes the development of hypertension in Cyp1a1-Ren-2 transgenic rats.
Erbanová M; Thumová M; Husková Z; Vanecková I; Vanourková Z; Mullins JJ; Kramer HJ; Bürgelová M; Rakusan D; Cervenka L
J Hypertens; 2009 Mar; 27(3):575-86. PubMed ID: 19330918
[TBL] [Abstract][Full Text] [Related]
17. Gradual hypertension induction in middle-aged Cyp1a1-Ren2 transgenic rats produces significant impairments in spatial learning.
Willeman MN; Chawla MK; Zempare MA; Biwer LA; Hoang LT; Uprety AR; Fitzhugh MC; De Both M; Coleman PD; Trouard TP; Alexander GE; Mitchell KD; Barnes CA; Hale TM; Huentelman M
Physiol Rep; 2019 Mar; 7(6):e14010. PubMed ID: 30916484
[TBL] [Abstract][Full Text] [Related]
18. Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs.
Farina NK; Johnston CI; Burrell LM
J Hypertens; 2000 Jun; 18(6):749-55. PubMed ID: 10872560
[TBL] [Abstract][Full Text] [Related]
19. Renal vascular and tubulointerstitial inflammation and proliferation in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Graciano ML; Mouton CR; Patterson ME; Seth DM; Mullins JJ; Mitchell KD
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1858-66. PubMed ID: 17344186
[TBL] [Abstract][Full Text] [Related]
20. Tight blood glycaemic and blood pressure control in experimental diabetic nephropathy reduces extracellular matrix production without regression of fibrosis.
Conway BR; Betz B; Sheldrake TA; Manning JR; Dunbar DR; Dobyns A; Hughes J; Mullins JJ
Nephrology (Carlton); 2014 Dec; 19(12):802-13. PubMed ID: 25196678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
